Servicios Personalizados
Revista
Articulo
Indicadores
Citado por SciELO
Accesos
Links relacionados
Citado por Google
Similares en
SciELO
Similares en Google
Compartir
Infectio
versión impresa ISSN 0123-9392
Resumen
PELAEZ-MARTINEZ, Juan David et al. Screening and Distribution of High-Risk HPV Genotypes in Women from Cali, Colombia in 2023: Results from the Por Ti Mujer Program. Infect. [online]. 2025, vol.29, n.3, pp.150-158. Epub 10-Sep-2025. ISSN 0123-9392. https://doi.org/10.22354/24223794.1236.
Introduction:
Persistent high-risk human papillomavirus (HPV) infections are strongly associated with cervical cancer, the leading cause of cancer-related deaths among women aged 30-59 years in Colombia. This study presents the screening results and distribution of high-risk HPV genotypes in women enrolled in the Por Ti Mujer programme in Cali, Colombia.
Materials and Methods:
A cross-sectional descriptive observational study was conducted using medical records of adult women screened using conventional cytology, high-risk HPV DNA testing, and visual inspection with acetic acid and lugol's iodine. Data were collected between January and June 2023 using the Por Ti Mujer program.
Results:
A total of 15,130 records were analyzed. Overall positivity, regardless of screening method, was 10.2%; positivity for HPV DNA was 15.2%, and positivity for cytology was 5.4%. Women aged 30-65 years and those in the contributory health insurance scheme group had higher rates of abnormal results. The most frequent high-risk HPV genotypes were 56-59-66 (21.2%), 33-39-68 (17.0%), 16 (13.8%), 33-58 (12.1%), and 52 (11.1%).
Discussion:
The HPV DNA positivity rate in the Por Ti Mujer program (15.2%) was higher than the global average (10.4%), but lower than the regional Latin American estimate (16.1%). The most prevalent genotypes were 56-59-66 and 33-39-68.
Palabras clave : Papillomavirus infection; mass screening; genotype; cervical cancer; cytology.












